Skip Ribbon Commands
Skip to main content
 
Chronic Malignancies

Introduction

The CMWP promotes and conduct educational activities and clinical investigations on hematopoietic stem cell transplantation in chronic haematological malignancies. 

The CMWP consists of four subcommittees: 

  1. Chronic Myeloproliferative Disorders
  2. Chronic Lymphocytic Leukemia
  3. Plasma Cell Disorders
  4. Myelodysplastic Syndromes 

The mission of the CMWP is to contribute significantly to an improved  outcome of stem cell transplantation in chronic hematological malignancies by: 

  1. performing high quality retrospective registry studies
  2. performing prospective clinical trials and non-interventional studies (NIS)
  3. improving quality of data  in collaboration with other WP and the registry committee
  4. promoting advanced training and scientific interaction by performing “Educational Courses” and “Scientific Meetings”
  5. collaboration with national and international Transplant – and Non-transplant (disease-specific) Groups
  6. disseminating knowledge by up-to date information to the transplant and non-transplant scientific community, patient organization and lay public. 

Meetings

Business meeting, 20 January 2017 in Paris

Educational event “New insight into pathogenesis and treatment of MDS”, 21 January 2017

EDUCATIONAL EVENTS

REPLY FORM

 

CMWP Team 

Chairperson
Nicolaus Kröger
nkroeger@uke.uni-hamburg.de






 
Secretary
Stefan Schönland
Stefan.Schoenland@med.uni-heidelberg.de
 
  

 
 
 
Statisticians
Simona Iacobelli​
​Liesbeth de Wreede
Dimitris Ziagkos
 
Study Coordinator head
Anja van Biezen
 
Study Coordinators
​Jennifer Hoek
Anja Henseler
Linda Koster
 
Chairs / Vice-Chair of Plasma cell disorder subcommittee
Laurent Garderet
​Stefan Schönland
 
Myelodysplasia
​Marie Robin ​
Theo de Witte
 
Chronic lymphocytic leukemia
Johannes Schetelig
​Michel van Gelder
 
Myeloproliferative neoplasias
Yves Chalandon
Eduardo Olavarria
 

List of Membersist of Members

 
Please click on this CMWP_memberlist_2013.xlsx to view the list of Members.
 

Related documents

Click HERE to view the publication list 

 

Studies Coordinated by the CMWP

 

Click HERE to view the Current Research list

  • Non-interventional prospective study on the on the effect of 2nd generation TKI prior to HSCT in CML
  • Non-interventional Study on alloHSCT in 17p-CLL
  • Non-interventional prospective study on iron toxicity in allogeneic transplanted MDS and CMML
  • Non-interventional prospective study on prognostic factors for autologous SCT outcomes in MM
  • CALM: Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma
  • Plerifaxor Off-label Transplant Use
  • Data quality check in allogeneic CLL
  • Dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation in patients with MDS or sAML: A randomised phase III study
  • Observational study on the use of B cell receptor kinase inhibitors and BCL2 antagonists prior to allogeneic hematopoietic stem cell transplantation for B cell malignancies: A joint project of the EBMT Lymphoma and Chronic Malignancy Working Parties.
  • Data quality check in MDS
  • Data quality check in MPN
  • Consensus on allogeneic SCT for MDS (in collaboration with ELN)
  • Consensus on allogeneic SCT for MPN (in collaboration with ELN)
  • Consensus on relapse after autografting in Multiple Myeloma (in collaboration with ASBMT, IWG MM, BMT-CTN)

How to get involved?

 
Please contact the Chairperson or the Secretary.
 


 
 

 News

 
17/05/2017
The EBMT implements Elsevier’s MACRO platform to upgrade patient registry.... Read more >>
05/10/2016
​EBMT TV returns to 2017 Annual Meeting... Read more >>
26/09/2016
​The EBMT has contributed to the Innovative Medicines Intiative... Read more >>
10/05/2016
​More than 60 EBMT centres have already started entering their related donor data. We want to invite... Read more >>
 

 Events

 
Bookmark and Share